Tech Company Financing Transactions
Path Fertility Funding Round
National Institutes of Health and NICHD participated in a $2 million funding round for Path Fertility. This VC investment round was announced on 11/4/2026.
Transaction Overview
Company Name
Announced On
11/4/2026
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
National Institutes of Health (Lead Investor)
Proceeds Purpose
The company intends to use the funds to fund the development and clinical validation of an epigenetic diagnostic for non-obstructive azoospermia (NOA) and its associated cancer risk.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
26 S. Rio Grande Street 2072
Salt Lake City, UT 84101
USA
Salt Lake City, UT 84101
USA
Phone
Website
Email Address
Overview
Path Fertility is a fertility diagnostics company focused on improving male reproductive health. It developed SpermQT, an epigenetic-based sperm quality test that helps identify male fertility issues that may not be detected through standard semen analysis. The company works with doctors and fertility specialists to help couples make informed fertility treatment decisions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andy Olson
Chief Scientific Officer
Kristin Brogaard
Browse more venture capital transactions:
Prev: 11/4/2026: mamun venture capital transaction
Next: 11/4/2026: Pliant venture capital transaction
Share this article
About Database of VC Transactions
We document every notable VC transaction. All VC database entries reported here are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs